The purpose of this paper is to present 4 cases that illustrate the management and outcome of subdural hematoma (SDH) following deep brain stimulation (DBS) lead implantation.
The authors identified 4 cases of SDH following DBS lead implantation from a pool of 500 consecutive lead implantations (incidence 0.08%) performed at the University of Florida. Cases were characterized by chart review, serial Unified Parkinson's Disease Rating Scale evaluations, and changes on serial postoperative imaging studies.
Two of the 4 patients with DBS-related SDH were clinically symptomatic. In the other 2 cases the SDH was incidentally discovered on routine postoperative lead localization imaging studies. None of the patients required craniotomy for evacuation of the SDH in the acute phase. Three of the 4 cases were managed with bur hole drainage in the chronic phase, and one was successfully managed nonoperatively. In all 4 cases, thresholds for stimulationinduced side effects were lower during initial postoperative programming than during intraoperative macrostimulation. Expected clinical improvement from DBS was achieved without lead revision in all 4 cases, but only after a significant delay.
Subdural hematoma is a rare and potentially avoidable complication of DBS that does not typically mandate acute hematoma evacuation or hardware revision and does not preclude an excellent outcome from DBS therapy. The clinical picture and apparent lead position tend to improve with time, and it may be wise to delay repositioning of an ineffective DBS lead following a hemorrhage until the DBS lead and surrounding brain tissue have settled into their final position and the insulted brain has had sufficient time to recover.
IshikawaT, , KawamuraS, , HadeishiH, , SuzukiA, , YasuiN, & ShishidoF, et al.: Uncoupling between CBF and oxygen metabolism in a patient with chronic subdural haematoma: case report. J Neurol Neurosurg Psychiatry55:401–403, 1992
IshikawaT, KawamuraS, HadeishiH, SuzukiA, YasuiN, ShishidoF, : Uncoupling between CBF and oxygen metabolism in a patient with chronic subdural haematoma: case report. J Neurol Neurosurg Psychiatry55:401–403, 1992)| false
KenneyC, , SimpsonR, , HunterC, , OndoW, , AlmaguerM, & DavidsonA, et al.: Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders. J Neurosurg106:621–625, 2007
KollerW, , PahwaR, , BusenbarkK, , HubbleJ, , WilkinsonS, & LangA, et al.: High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol42:292–299, 1997
ServelloD, , SassiM, , BastianelloS, , PoloniGU, , ManciniF, & PacchettiC: Electrode displacement after intracerebral hematoma as a complication of a deep brain stimulation procedure. Neuropsychiatr Dis Treat5:183–187, 2009
ServelloD, SassiM, BastianelloS, PoloniGU, ManciniF, PacchettiC: Electrode displacement after intracerebral hematoma as a complication of a deep brain stimulation procedure. Neuropsychiatr Dis Treat5:183–187, 2009)| false
SimuniT, , JaggiJL, , MulhollandH, , HurtigHI, , ColcherA, & SiderowfAD, et al.: Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety. J Neurosurg96:666–672, 2002
SimuniT, JaggiJL, MulhollandH, HurtigHI, ColcherA, SiderowfAD, : Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety. J Neurosurg96:666–672, 2002)| false